Latest News and Press Releases

New York, July 11, 2023 (GLOBE NEWSWIRE) -- The global mesenchymal stem cells market is slated to grow at a CAGR of ~14% between 2023 and 2035. The market is estimated to garner a revenue of ~USD 17...

Dublin, June 09, 2023 (GLOBE NEWSWIRE) -- The "Cell Isolation/ Cell Separation Market by Product (Consumables, Instruments), Cell Type (Human Cells, Animal Cells), Cell Source (Bone Marrow, Adipose...

Dublin, June 18, 2021 (GLOBE NEWSWIRE) -- The "Global Cell Isolation Market By Product (Consumables and Instruments), By Cell Type (Human Cells and Animal Cells), By Source, By Technique, By...

EATONTOWN, N.J., July 2, 2014 (GLOBE NEWSWIRE) -- American CryoStem Corporation (OTCQB:CRYO), a leading strategic developer, marketer and global licensor of patented adipose tissue-based cellular...

EATONTOWN, N.J., June 18, 2014 (GLOBE NEWSWIRE) -- American CryoStem Corporation (OTCQB:CRYO), a leading strategic developer, marketer and global licensor of patented adipose tissue-based cellular...

Combined Technologies Create Basis for Joint Development of Multi-Functional Nanotechnology Platforms EATONTOWN, N.J., April 10, 2014 (GLOBE NEWSWIRE) -- American CryoStem Corporation...

EATONTOWN, N.J., Jan. 6, 2014 (GLOBE NEWSWIRE) -- John Arnone, Chairman and CEO of American CryoStem Corporation (OTCQB:CRYO), a leading strategic developer, marketer and global licensor of patented...

EATONTOWN, N.J., Nov. 14, 2013 (GLOBE NEWSWIRE) -- American CryoStem Corporation (OTCQB:CRYO), a leading strategic developer, marketer and global licensor of patented adipose tissue-based cellular...

EATONTOWN, N.J., Sept. 25, 2013 (GLOBE NEWSWIRE) -- American CryoStem Corporation (OTCQB:CRYO), a leading strategic developer, marketer and global licensor of patented adipose tissue-based cellular...

EATONTOWN, N.J., July 10, 2013 (GLOBE NEWSWIRE) -- American CryoStem Corporation (OTCQB:CRYO), a leading strategic developer, marketer and global licensor of patented adipose tissue-based cellular...